×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs : Pr Jérôme Alexandre & Dr Enora Laas


Cas clinique :  

18:30
Mise en pratique des données de DESKTOP III :

 - Recommandations de surveillance à la fin du traitement initial - Pr Jérôme Alexandre

- Nouvelles stratégies chirurgicales en rechute - Dr Enora Laas
 
19:10
Espérance de vie des patientes sous iPARP : quels nouveaux enjeux en maintenance ?
Dr Manuel Rodrigues
 
19:35
Quelles possibilités de suivi des patientes sous iPARP en pratique courante ?
Mme Pascale Dielenseger
19:45
Discussion Q&A
 

 

Shooting date : 2021-06-22
Last update : 2021-06-29
1 comment
Join the Discussion
  • l D. quand pourra-t-on avoir le replay? Merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Friday, March 21st 2025 from 02pm to 06:30pm (GMT+1)
    Honolulu : Friday, March 21st 2025 from 02am to 06:30am (GMT+1)
    San Francisco : Friday, March 21st 2025 from 04am to 08:30am (GMT+1)
    New York : Friday, March 21st 2025 from 07am to 11:30am (GMT+1)
    Buenos Aires : Friday, March 21st 2025 from 09am to 01:30pm (GMT+1)
    London / Dublin : Friday, March 21st 2025 from 12pm to 04:30pm (GMT+1)
    Paris / Berlin : Friday, March 21st 2025 from 01pm to 05:30pm (GMT+1)
    Istanbul : Friday, March 21st 2025 from 02pm to 06:30pm (GMT+1)
    Moscou / Dubaï : Friday, March 21st 2025 from 04pm to 08:30pm (GMT+1)
    Bangkok : Friday, March 21st 2025 from 07pm to 11:30pm (GMT+1)
    Shanghai : Friday, March 21st 2025 from 08pm to 12:30am (GMT+1)
    Tokyo : Friday, March 21st 2025 from 09pm to 01:30am (GMT+1)
    Sydney : Friday, March 21st 2025 from 10pm to 02:30am (GMT+1)
    Wellington : Saturday, March 22nd 2025 from 12am to 04:30am (GMT+1)

    Transpyrenean Oncogynae Symposium

    Advancing gynecologic oncology: from molecular insights to clinical practice

    Share
    Tuesday, March 22nd 2022 from 07pm to 08:50pm (GMT+1)
    Honolulu : Tuesday, March 22nd 2022 from 07am to 08:50am (GMT+1)
    San Francisco : Tuesday, March 22nd 2022 from 09am to 10:50am (GMT+1)
    New York : Tuesday, March 22nd 2022 from 12pm to 01:50pm (GMT+1)
    Buenos Aires : Tuesday, March 22nd 2022 from 02pm to 03:50pm (GMT+1)
    London / Dublin : Tuesday, March 22nd 2022 from 05pm to 06:50pm (GMT+1)
    Paris / Berlin : Tuesday, March 22nd 2022 from 06pm to 07:50pm (GMT+1)
    Istanbul : Tuesday, March 22nd 2022 from 07pm to 08:50pm (GMT+1)
    Moscou / Dubaï : Tuesday, March 22nd 2022 from 09pm to 10:50pm (GMT+1)
    Bangkok : Wednesday, March 23rd 2022 from 12am to 01:50am (GMT+1)
    Shanghai : Wednesday, March 23rd 2022 from 01am to 02:50am (GMT+1)
    Tokyo : Wednesday, March 23rd 2022 from 02am to 03:50am (GMT+1)
    Sydney : Wednesday, March 23rd 2022 from 03am to 04:50am (GMT+1)
    Wellington : Wednesday, March 23rd 2022 from 05am to 06:50am (GMT+1)

    Cancer de l’ovaire

    Cycle de formation en oncologie gynécologique et sénologique de l’Institut Curie

    Share
    Monday, September 25th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Monday, September 25th 2023 from 06:30am to 08am (GMT+2)
    San Francisco : Monday, September 25th 2023 from 09:30am to 11am (GMT+2)
    New York : Monday, September 25th 2023 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Monday, September 25th 2023 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Monday, September 25th 2023 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Monday, September 25th 2023 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Monday, September 25th 2023 from 06:30pm to 08pm (GMT+2)
    Istanbul : Monday, September 25th 2023 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Monday, September 25th 2023 from 08:30pm to 10pm (GMT+2)
    Bangkok : Monday, September 25th 2023 from 11:30pm to 01am (GMT+2)
    Shanghai : Tuesday, September 26th 2023 from 12:30am to 02am (GMT+2)
    Tokyo : Tuesday, September 26th 2023 from 01:30am to 03am (GMT+2)
    Sydney : Tuesday, September 26th 2023 from 03:30am to 05am (GMT+2)
    Wellington : Tuesday, September 26th 2023 from 05:30am to 07am (GMT+2)

    Les scores indispensables dans la prise en charge des cancers de l'ovaire

    Cycle d'enseignement - Les cancers gynécologiques

    Share
    Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, October 10th 2023 from 06:30am to 08am (GMT+2)
    San Francisco : Tuesday, October 10th 2023 from 09:30am to 11am (GMT+2)
    New York : Tuesday, October 10th 2023 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Tuesday, October 10th 2023 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Tuesday, October 10th 2023 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Tuesday, October 10th 2023 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
    Istanbul : Tuesday, October 10th 2023 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Tuesday, October 10th 2023 from 08:30pm to 10pm (GMT+2)
    Bangkok : Tuesday, October 10th 2023 from 11:30pm to 01am (GMT+2)
    Shanghai : Wednesday, October 11th 2023 from 12:30am to 02am (GMT+2)
    Tokyo : Wednesday, October 11th 2023 from 01:30am to 03am (GMT+2)
    Sydney : Wednesday, October 11th 2023 from 03:30am to 05am (GMT+2)
    Wellington : Wednesday, October 11th 2023 from 05:30am to 07am (GMT+2)

    La prise en charge du cancer de l’ovaire chez la personne âgée : expériences croisées du CGFL ...

    Cycle d'enseignement sur le cancer de l'ovaire - Deuxième session

    Share
    Scroll Up